AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 49 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $24,000 | +100.0% | 161,612 | +103.3% | 0.00% | +100.0% |
| Q3 2019 | $12,000 | +50.0% | 79,509 | +68.7% | 0.00% | – |
| Q2 2019 | $8,000 | -85.5% | 47,137 | -83.1% | 0.00% | -100.0% |
| Q1 2019 | $55,000 | +120.0% | 278,958 | +675.7% | 0.00% | +200.0% |
| Q4 2018 | $25,000 | +56.2% | 35,964 | +174.2% | 0.00% | 0.0% |
| Q3 2018 | $16,000 | -64.4% | 13,115 | -63.4% | 0.00% | -50.0% |
| Q3 2017 | $45,000 | – | 35,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,070,000 | $1,990,000 | 0.99% |
| 22NW, LP | 155,000 | $288,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 405,000 | $753,000 | 0.15% |
| Broadfin Capital, LLC | 500,000 | $930,000 | 0.11% |
| DLD Asset Management, LP | 237,100 | $438,000 | 0.07% |
| Birchview Capital, LP | 68,000 | $126,000 | 0.07% |
| CARL DOMINO INC | 33,273 | $62,000 | 0.07% |
| R&F Capital Advisors LP | 84,268 | $157,000 | 0.04% |
| TFS CAPITAL LLC | 49,461 | $92,000 | 0.03% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $45,000 | 0.03% |